High-dose topotecan, thiotepa and melphalan (TTM regimen) with autologous stem cell support for adult metastatic soft tissue sarcoma

被引:0
|
作者
Naparstek, E [1 ]
Harishanu, Y [1 ]
Rom, E [1 ]
Gipstein, L [1 ]
Aviv, F [1 ]
机构
[1] Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S258 / S259
页数:2
相关论文
共 50 条
  • [31] Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support
    vanWarmerdam, LJC
    Rodenhuis, S
    vanderWall, E
    Maes, RAA
    Beijnen, JH
    BRITISH JOURNAL OF CANCER, 1996, 73 (08) : 979 - 984
  • [32] Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
    C Pasqualini
    C Dufour
    G Goma
    M-A Raquin
    V Lapierre
    D Valteau-Couanet
    Bone Marrow Transplantation, 2016, 51 : 227 - 231
  • [33] High-dose thiotepa, melphalan and carboplatin followed by autologous peripheral blood stem cell transplantation in patients with lymphoma - a retrospective evaluation
    Demirer, T
    Soydan, E
    Fen, T
    Ilhan, O
    Ayli, M
    Arat, M
    Ozcan, M
    Gunel, N
    Arslan, O
    Genc, Y
    Uysal, A
    Haznedar, R
    Buyukberber, S
    Gurman, G
    Ustaer, N
    Hazar, B
    Ozet, G
    Akan, H
    BONE MARROW TRANSPLANTATION, 2004, 33 : S250 - S250
  • [34] High-dose therapy for adult soft tissue sarcoma: Dose response and survival
    Elias, AD
    SEMINARS IN ONCOLOGY, 1998, 25 (02) : 19 - 23
  • [35] High-Dose Melphalan Plus Thiotepa as Conditioning Regimen before Second Autologous Stem Cell Transplantation for "De Novo" Multiple Myeloma Patients: A Phase II Study
    Musso, Maurizio
    Messina, Giuseppe
    Marcacci, Gianpaolo
    Crescimanno, Alessandra
    Console, Giuseppe
    Donnarumma, Daniela
    Scalone, Renato
    Pinto, Antonio
    Martino, Massimo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (11) : 1932 - 1938
  • [36] HIGH-DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AL AMYLOIDOSIS PATIENTS
    Michael, M.
    Kastritis, E.
    Delimbassi, S.
    Kyrtsonis, M. C.
    Papadimetriou, C.
    Apostolides, I.
    Panayiotidis, P.
    Harhalakis, N.
    Pangalis, G.
    Dimopoulos, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 469 - 470
  • [37] Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas
    Jae-Cheol Jo
    Jin-Seok Kim
    Je-Hwan Lee
    Jung-Hee Lee
    Seong Nam Im
    Sang-Min Lee
    Sung-Soo Yoon
    In-Ho Kim
    Seong Hwa Bae
    Yoo Jin Lee
    Yunsuk Choi
    Won-Sik Lee
    Annals of Hematology, 2021, 100 : 189 - 196
  • [38] Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas
    Jo, Jae-Cheol
    Kim, Jin-Seok
    Lee, Je-Hwan
    Lee, Jung-Hee
    Im, Seong Nam
    Lee, Sang-Min
    Yoon, Sung-Soo
    Kim, In-Ho
    Bae, Seong Hwa
    Lee, Yoo Jin
    Choi, Yunsuk
    Lee, Won-Sik
    ANNALS OF HEMATOLOGY, 2021, 100 (01) : 189 - 196
  • [39] Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: No improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin
    Ayash, LJ
    Elias, A
    Schwartz, G
    Wheeler, C
    Ibrahim, J
    Teicher, BA
    Reich, E
    Warren, D
    Lynch, C
    Richardson, P
    Schnipper, L
    Frei, E
    Antman, K
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) : 2984 - 2992
  • [40] High-dose melphalan with BCNU and etoposide as preparative regimen for autologous hemopoietic stem cell transplantation in multiple myeloma (MM)
    Bernasconi, P
    Alessandrino, EP
    Colombo, AA
    Caldera, D
    Bonfichi, M
    Martinelli, G
    Malcovati, L
    Varettoni, M
    Maiocchi, M
    Brusamolino, E
    Pagnucco, G
    Castagnola, C
    Corso, A
    Bernasconi, C
    BONE MARROW TRANSPLANTATION, 1999, 23 : S133 - S133